Annual Long Term Debt
$18.48 B
-$971.00 M-4.99%
31 December 2023
Summary:
Teva Pharmaceutical Industries Limited annual long term debt is currently $18.48 billion, with the most recent change of -$971.00 million (-4.99%) on 31 December 2023. During the last 3 years, it has fallen by -$4.73 billion (-20.37%). TEVA annual long term debt is now -43.18% below its all-time high of $32.52 billion, reached on 31 December 2016.TEVA Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Debt
$16.70 B
-$133.00 M-0.79%
30 September 2024
Summary:
Teva Pharmaceutical Industries Limited quarterly long term debt is currently $16.70 billion, with the most recent change of -$133.00 million (-0.79%) on 30 September 2024. Over the past year, it has dropped by -$2.12 billion (-11.29%). TEVA quarterly long term debt is now -50.62% below its all-time high of $33.81 billion, reached on 30 June 2017.TEVA Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TEVA Long Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -5.0% | -11.3% |
| 3 y3 years | -20.4% | -22.2% |
| 5 y5 years | -30.8% | -31.0% |
TEVA Long Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -20.4% | at low | -24.2% | at low |
| 5 y | 5 years | -30.8% | at low | -33.3% | at low |
| alltime | all time | -43.2% | >+9999.0% | -50.6% | >+9999.0% |
Teva Pharmaceutical Industries Limited Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $16.70 B(-0.8%) |
| June 2024 | - | $16.83 B(-0.3%) |
| Mar 2024 | - | $16.88 B(-8.7%) |
| Dec 2023 | $18.48 B(-5.0%) | $18.48 B(-1.8%) |
| Sept 2023 | - | $18.82 B(-1.1%) |
| June 2023 | - | $19.04 B(-4.9%) |
| Mar 2023 | - | $20.01 B(+2.9%) |
| Dec 2022 | $19.45 B(-11.7%) | $19.45 B(+3.2%) |
| Sept 2022 | - | $18.85 B(-9.1%) |
| June 2022 | - | $20.73 B(-2.4%) |
| Mar 2022 | - | $21.23 B(-3.6%) |
| Dec 2021 | $22.03 B(-5.1%) | $22.03 B(+2.7%) |
| Sept 2021 | - | $21.46 B(-2.6%) |
| June 2021 | - | $22.05 B(-3.0%) |
| Mar 2021 | - | $22.73 B(-2.1%) |
| Dec 2020 | $23.21 B(-7.1%) | $23.21 B(-3.2%) |
| Sept 2020 | - | $23.99 B(-4.2%) |
| June 2020 | - | $25.03 B(+0.6%) |
| Mar 2020 | - | $24.88 B(-0.5%) |
| Dec 2019 | $25.00 B(-6.4%) | $25.00 B(+3.3%) |
| Sept 2019 | - | $24.21 B(-8.2%) |
| June 2019 | - | $26.38 B(+0.5%) |
| Mar 2019 | - | $26.26 B(-1.7%) |
| Dec 2018 | $26.70 B(-7.4%) | $26.70 B(-0.4%) |
| Sept 2018 | - | $26.82 B(-7.4%) |
| June 2018 | - | $28.96 B(-1.6%) |
| Mar 2018 | - | $29.45 B(+2.2%) |
| Dec 2017 | $28.83 B(-11.4%) | $28.83 B(-9.8%) |
| Sept 2017 | - | $31.97 B(-5.4%) |
| June 2017 | - | $33.81 B(+3.4%) |
| Mar 2017 | - | $32.69 B(+0.5%) |
| Dec 2016 | $32.52 B(+289.1%) | $32.52 B(-2.0%) |
| Sept 2016 | - | $33.18 B(+312.9%) |
| June 2016 | - | $8.04 B(-6.8%) |
| Mar 2016 | - | $8.62 B(+3.1%) |
| Dec 2015 | $8.36 B(-2.4%) | $8.36 B(-12.2%) |
| Sept 2015 | - | $9.52 B(+0.2%) |
| June 2015 | - | $9.50 B(+1.1%) |
| Mar 2015 | - | $9.39 B(+9.6%) |
| Dec 2014 | $8.57 B(-17.5%) | $8.57 B(-2.9%) |
| Sept 2014 | - | $8.82 B(-3.3%) |
| June 2014 | - | $9.12 B(-11.0%) |
| Mar 2014 | - | $10.24 B(-1.4%) |
| Dec 2013 | $10.39 B(-11.3%) | $10.39 B(+3.2%) |
| Sept 2013 | - | $10.06 B(+1.4%) |
| June 2013 | - | $9.93 B(-0.1%) |
| Mar 2013 | - | $9.94 B(-15.1%) |
| Dec 2012 | $11.71 B(+14.4%) | $11.71 B(-7.7%) |
| Sept 2012 | - | $12.69 B(+0.5%) |
| June 2012 | - | $12.63 B(+24.3%) |
| Mar 2012 | - | $10.16 B(-0.8%) |
| Dec 2011 | $10.24 B(+149.1%) | $10.24 B(+134.5%) |
| Sept 2011 | - | $4.37 B(+11.4%) |
| June 2011 | - | $3.92 B(-19.6%) |
| Mar 2011 | - | $4.88 B(+18.7%) |
| Dec 2010 | $4.11 B(-4.7%) | $4.11 B(-13.3%) |
| Sept 2010 | - | $4.74 B(-6.5%) |
| June 2010 | - | $5.07 B(+22.5%) |
| Mar 2010 | - | $4.14 B(-4.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2009 | $4.31 B(-22.1%) | $4.31 B(-13.3%) |
| Sept 2009 | - | $4.97 B(-7.5%) |
| June 2009 | - | $5.37 B(-5.8%) |
| Mar 2009 | - | $5.70 B(+3.0%) |
| Dec 2008 | $5.54 B(+65.4%) | $5.54 B(+41.4%) |
| Sept 2008 | - | $3.92 B(+17.9%) |
| June 2008 | - | $3.32 B(-0.8%) |
| Mar 2008 | - | $3.35 B(+0.0%) |
| Dec 2007 | $3.35 B(-27.0%) | $3.35 B(-0.3%) |
| Sept 2007 | - | $3.36 B(-15.6%) |
| June 2007 | - | $3.98 B(-0.6%) |
| Mar 2007 | - | $4.01 B(-12.6%) |
| Dec 2006 | $4.58 B(+158.6%) | $4.58 B(-1.8%) |
| Sept 2006 | - | $4.67 B(+1.9%) |
| June 2006 | - | $4.59 B(-0.2%) |
| Mar 2006 | - | $4.60 B(+159.2%) |
| Dec 2005 | $1.77 B(+17.2%) | $1.77 B(+17.2%) |
| Sept 2005 | - | $1.51 B(-0.0%) |
| June 2005 | - | $1.51 B(0.0%) |
| Mar 2005 | - | $1.51 B(+0.0%) |
| Dec 2004 | $1.51 B(+85.6%) | $1.51 B(-12.5%) |
| Sept 2004 | - | $1.73 B(-7.2%) |
| June 2004 | - | $1.86 B(-1.9%) |
| Mar 2004 | - | $1.90 B(+133.0%) |
| Dec 2003 | $815.40 M(-29.8%) | $815.40 M(+81.2%) |
| Sept 2003 | - | $450.00 M(-44.4%) |
| June 2003 | - | $810.00 M(-30.3%) |
| Mar 2003 | - | $1.16 B(+0.1%) |
| Dec 2002 | $1.16 B(-6.9%) | $1.16 B(-7.4%) |
| Sept 2002 | - | $1.25 B(-1.8%) |
| June 2002 | - | $1.28 B(+2.0%) |
| Mar 2002 | - | $1.25 B(+0.4%) |
| Dec 2001 | $1.25 B(+53.2%) | $1.25 B(-0.2%) |
| Sept 2001 | - | $1.25 B(+55.9%) |
| June 2001 | - | $801.93 M(-0.6%) |
| Mar 2001 | - | $806.61 M(-0.9%) |
| Dec 2000 | $813.89 M(+107.9%) | $813.89 M(+120.9%) |
| June 2000 | - | $368.37 M(-5.2%) |
| Mar 2000 | - | $388.77 M(-0.7%) |
| Dec 1999 | $391.42 M(+94.1%) | $391.42 M(+27.0%) |
| Sept 1999 | - | $308.30 M(+51.4%) |
| June 1999 | - | $203.60 M(+1.1%) |
| Mar 1999 | - | $201.30 M(-0.2%) |
| Dec 1998 | $201.70 M(+55.3%) | $201.70 M(-0.2%) |
| Sept 1998 | - | $202.10 M(+0.9%) |
| June 1998 | - | $200.30 M(+77.1%) |
| Mar 1998 | - | $113.10 M(-12.9%) |
| Dec 1997 | $129.90 M(-19.4%) | $129.90 M(-19.4%) |
| Dec 1996 | $161.10 M(+72.9%) | $161.10 M(+72.9%) |
| Dec 1995 | $93.20 M(+15.3%) | $93.20 M(+15.3%) |
| Dec 1994 | $80.80 M(+16.6%) | $80.80 M(+16.6%) |
| Dec 1993 | $69.30 M(+87.3%) | $69.30 M(+87.3%) |
| Dec 1992 | $37.00 M(-36.1%) | $37.00 M(-36.1%) |
| Dec 1991 | $57.90 M(-15.6%) | $57.90 M(-15.6%) |
| Dec 1990 | $68.60 M(+3.2%) | $68.60 M(+3.2%) |
| Dec 1989 | $66.50 M(+66.7%) | $66.50 M(+66.7%) |
| Dec 1988 | $39.90 M(+88.2%) | $39.90 M(+88.2%) |
| Mar 1987 | $21.20 M(-15.5%) | $21.20 M(-15.5%) |
| Mar 1986 | $25.10 M | $25.10 M |
FAQ
- What is Teva Pharmaceutical Industries Limited annual long term debt?
- What is the all time high annual long term debt for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited annual long term debt year-on-year change?
- What is Teva Pharmaceutical Industries Limited quarterly long term debt?
- What is the all time high quarterly long term debt for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited quarterly long term debt year-on-year change?
What is Teva Pharmaceutical Industries Limited annual long term debt?
The current annual long term debt of TEVA is $18.48 B
What is the all time high annual long term debt for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high annual long term debt is $32.52 B
What is Teva Pharmaceutical Industries Limited annual long term debt year-on-year change?
Over the past year, TEVA annual long term debt has changed by -$971.00 M (-4.99%)
What is Teva Pharmaceutical Industries Limited quarterly long term debt?
The current quarterly long term debt of TEVA is $16.70 B
What is the all time high quarterly long term debt for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high quarterly long term debt is $33.81 B
What is Teva Pharmaceutical Industries Limited quarterly long term debt year-on-year change?
Over the past year, TEVA quarterly long term debt has changed by -$2.12 B (-11.29%)